“…Currently, several molecules are being tested for their efficiency on COVID-19 disease, some of which have reached clinical trials, while others are still in the preclinical phase ( Sanders et al, 2020 , Luo et al, 2020 , Colaneri et al, 2020 , Quartuccio et al, 2020 , Campochiaro et al, 2020 ). Quinoxaline as a wonder nucleus in the fused systems of nitrogen-containing heterocycles, is important nitrogenous hetero compound due to their extensive properties, ( Ramli and Essassi, 2015 , Ramli et al, 2014 , Zarrok et al, 2012 , Tazouti et al, 2016 , El Aoufir et al, 2016 , Laabaissi et al, 2019 ) and shows a variety of activities in the medical field, including analgesic ( Dewangan et al, 2018 ), anti-inflammatory ( Shen et al, 2020 )anti-tubercular ( Srinivasarao et al, 2020 ), anti-bacterial ( Patel et al, 2019 ), bacteriocides ( Thakuria and Das, 2006 ), anti-HIV ( Patel et al, 2016 ), anti-diabetic ( Kulkarni et al, 2012 ), anti-oxydant ( Missioui et al, 2021 ) and anti-cancer ( Guerreiro et al, 2020 , Abad et al, 2021 ) agents. Malonate-based compounds have aroused increasing attention because of their important pharmacological activities, such as decreased blood glucose ( Shinkai et al, 1998 ) anti-HIV ( Serafin et al, 2011 ) anticancer ( Xing et al, 2012 ) anti-inflammatory ( Kim et al, 2001 ) antioxidative ( Saranya et al, 2013 ) and antiviral ( Xiao et al, 2014 ) activities.…”